Stem cell transplant using your own cells for Crohn’s flare
Treatments studied
Part of Digestive system clinical trials.
This Phase 2 study tests whether a transplant using your own stem cells can calm active Crohn’s disease that hasn’t improved with standard medicines. It may help some people with ongoing inflammation and symptoms after multiple Crohn’s treatments.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with Crohn’s disease.
- Your Crohn’s is active right now, based on symptoms and intestinal inflammation on scope/endoscopy.
- You’ve tried key Crohn’s medicines (including steroids and several other listed drug types) but they didn’t work or you couldn’t tolerate them.
- You’re at least 18 years old and can do daily activities at a basic level (Karnofsky score 60 or higher).
- You do not have a serious active infection, or any heart/lung limits that make treatment unsafe.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This early-phase study tests whether a stem cell transplant can improve Crohn’s disease in teens and young adults whose disease is active and not responding to standard medicines. It may help some people who are not doing well despite several prior treatments, but it also involves intensive study procedures and safety checks.
This trial tests whether a stem cell transplant from a partially-matched family or unrelated donor can help treat severe Crohn's disease that has a known or suspected genetic cause or does not get better with standard treatments.
This trial tests whether injecting donated stem cells into complex anal fistulas can help heal them in people with Crohn's disease. You may qualify if you have a fistula that hasn't improved with standard treatments.
This study tests if a standardized fecal transplant is safe and helpful for adults with moderately to severely active Crohn's disease who are already on maintenance therapy. The goal is to see if this treatment can reduce inflammation in the digestive tract.
This trial tests a low dose of IL-2 to reduce inflammation and help control Crohn’s disease symptoms. It’s for people whose Crohn’s disease hasn’t responded to at least one standard treatment or who need steroids to stay under control.
This study tests whether a combination of fecal transplant (transferring healthy bacteria from a donor) and dietary changes can help control disease activity in people newly diagnosed with Crohn's. It is for those with mild to moderate symptoms who have not yet taken any Crohn's medications.
Hear when a new Crohn Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.